IQ4I Research & Consultancy Published a New Report on "3D Cell Culture Global Market - Forecast to 2021"
This report analyzes the 3D cell culture global market, major drivers & opportunities, restraints & threats in North America, Europe, Asia-Pacific and Rest of the World
Bangalore, India, January 5, 2016 (Newswire.com) - This report analyzes the 3D Cell Culture global market in terms of market revenue ($ million) for all segments and it enables Cell culture products manufacturers, 3D Cell culture products distributors and wholesalers, Research laboratories and hospitals, Biobanks, Bulk purchasing organizations, Biopharmaceutical companies, Research associations related to cell culture, Various research and consulting firms, Contract research organizations (CROs) and other associated stake holders to identify and analyze market expansion opportunities, upcoming technologies, technological developments, competition in 3D Cell Culture global market.
3D cell culture is accepted as a new dimension of cell culture sector in biomedical research field. Cells grown on two-dimensional (2D) substrates do not represent true in-vivo cell environment and lack extracellular components, cell-cell and cell-matrix interactions necessary for differentiation, proliferation and cell-based functions. Three-dimensional (3D) cell culture methods are much preferred over 2D models as they provide a matrix support that encourages cells to organize into structures more indicative of the in--vivo environment and help to overcome 2D related shortcomings. 3D cell culture adaption is rapidly advancing at an unprecedented rate, as estimated by IQ4I Research that the 3D Cell Culture global market is expected to reach $3,702.2 million by 2021.
The factors driving the growth of this market are rise in Research and Development Investments, rising need for organ transplantation, Use of 3D Cell Culture models as an alternative tool for invivo testing, Use of microfluidic technology and Increasing focus on regenerative medicine. However, Lack of experienced and skilled professionals ,Budget restriction for small and medium sized laboratories, Lack of consistency in 3D cell culture products, Stringent process controls for advanced handling capabilities, Ethical concern over use of animal sources issues are hampering the growth of the market.
The global 3D Cell culture market is segmented based on the product type, applications, end-users and geography. Based on the product type, 3D cell culture market is further segmented into 3D-technology and consumables. 3D-technologies includes scaffold based, scaffold free platforms, bioreactors, microchips and hydrogels. The consumables market covers cells and tissues, media and sera, microplates and reagents and assay kits. Based on applications, the 3D cell culture market is segmented into Basic research, Toxicity and drug safety screening, tissue engineering, stem cell research, drug discovery, cancer research and Gene therapy. The end-users market is segmented into academic institutes, biotechnology and pharmaceutical industries, hospitals and diagnostic centers and others.
Among the 3D cell culture technologies, scaffolds based segment occupy major share due to extensive use in but the development of advanced technologies such as hanging drop technology in combination with availability of biodegradable and bioabsorbable materials and hydrogels are favoring the growth of scaffold free technologies in the coming years. In order to boost the market further, major players are coming with advanced assay kits, which play a critical role in reducing the cost and efforts required in identification of diseases pathways, potential new drugs and evaluation of new biological processes.
Geographical wise North America is the major market, followed by Europe and Asia-pacific. The APAC region presents an array of opportunities for growth and is likely to be getting attention of new investors in the 3D cell culture market. Asia-pacific region is expected to grow at the highest CAGR due to increased healthcare awareness, improved economic growth, low operating cost and increased outsourcing. Significant new product launches, mergers and acquisitions, collaborations, joint ventures are some of the industry trends that are playing a major role for the market growth.
The major players operating in the 3-dimensional cell culture market are 3D Biomatrix, Inc (U.S.), 3D Biotek LLC (U.S.), Becton, Dickinson and Company (U.S.), Corning Incorporated (U.S.), Thermo Fisher Scientific (U.S.), Global Cell Solutions Inc, (U.S.), InSphero AG (Switzerland), Lonza Group (Switzerland), Nano 3D Biosciences (U.S.), Nanofiber Solutions Incorporation (U.S.), Sigma Aldrich Corporation (U.S.) and Reinnervate Ltd, (A subsidiary of ReproCELL) (U.K.).
Reasons for buying this report:
· Identification and analysis of the 3D cell culture global market by identifying various segments such as technology, applications, end-user and geography.
· Revenue forecast of the 3D cell culture market and strategic analysis of each submarket with respect to segmental growth trends.
· Identification of the major market trends and factors driving or inhibiting the growth of the global 3D cell culture market and Porter’s five forces model.
· Revenue forecast of the 3D cell culture market with respect to North America, Europe, Asia-Pacific and the Rest of the World (RoW) regions.
· Analysis of the opportunities for stakeholders by identifying the high-growth segments of the market.
· Identification of key technology developments and innovations driving the market
· Profiles of major players in 3D cell culture market with details of their product offerings, revenues, business strategies, SWOT analysis and market shares.
· Emerging players (84 companies) and their product offerings.